StoneWise
StoneWise is a technology company founded in 2018, dedicated to accelerating drug discovery through artificial intelligence. They leverage AI and deep expertise in drug R&D to offer an AI-driven drug design platform called StoneMIND®. This platform includes modules for information extraction, knowledge discovery, and molecular design, aiming to improve efficiency across the drug discovery pipeline from hit identification to preclinical candidate optimization. StoneWise's approach focuses on ultra-high throughput screening and multi-dimensional molecular generation and optimization. The company collaborates with leading institutions and pharmaceutical companies and has received recognition from top investors in the AI and medicine fields.
StoneWise
StoneWise is a technology company founded in 2018, dedicated to accelerating drug discovery through artificial intelligence. They leverage AI and deep expertise in drug R&D to offer an AI-driven drug design platform called StoneMIND®. This platform includes modules for information extraction, knowledge discovery, and molecular design, aiming to improve efficiency across the drug discovery pipeline from hit identification to preclinical candidate optimization. StoneWise's approach focuses on ultra-high throughput screening and multi-dimensional molecular generation and optimization. The company collaborates with leading institutions and pharmaceutical companies and has received recognition from top investors in the AI and medicine fields.